Paperless pharma: turbocharging development and production

Published: 15-Jun-2016
Regulatory Research & Development Digital

Alwyn Jones, Head of Pharmaceutical and Life Sciences, Siemens UK & Ireland, highlights the company’s new solution for paperless pharmaceutical production that boosts efficiency and makes it easier to introduce personalised cancer therapies, for example

You need to be a subscriber to read this article.
Click here to find out more.

Pharmaceutical products must be manufactured with perfection in mind. The slightest deviation from any production specification can quickly jeopardise the health and lives of human beings.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Manufacturing

Siemens debuts gen-AI powered maintenance technology for process manufacturers

Read more
The generative AI tech is designed to boost long-term quality and productivity by enabling effective industrial maintenance

Trending Articles

  1. SGS supports non-animal clinical testing with release of 3D skin model white paper SGS has announced the release of a new white paper: 3D reconstructed skin models: transforming clinical and safety testing
  2. UK point of care manufacturing legislation: why it matters On 23 July, new UK legislation governing vaccine manufacturing at point of care locations (such as hospitals and pharmacies) came into force, transforming the personal healthcare landscape
  3. Cytiva unveils new ÄKTA readyflux system for low-volume drug manufacturing Single-use platform designed to streamline technology transfers, improve consistency and reduce downtime
  4. 25 years of Guardtech: Isopod Manufacturing Director Michael Burton Q&A One of the Group’s longest-serving superstars gives his thoughts on why the Guardtech Group are pushing the boundaries of small-scale cleanroom provision with their rapid-assembly pod systems
  5. PhoreMost demonstrates new approach to rationalise molecular glue drug discovery Breakthrough data validates capabilities of GlueSEEKER platform to identify novel induced protein-protein interactions and expand druggable space

Upcoming event

POWTECH

23-25 September 2025 | Exhibition | Nuremberg, Germany See all

You may also like

Manufacturing

Siemens debuts gen-AI powered maintenance technology for process manufacturers

The generative AI tech is designed to boost long-term quality and productivity by enabling effective industrial maintenance
Regulatory

Covestro and Siemens conclude strategic supplier agreement

The agreement will be active for the next five years and will underpin all future business relationships
Manufacturing

Siemens commissioned study identifies key focus areas for business growth in UK and Irish biopharmaceutical sector

Digital Transformation at heart of introducing new efficiencies
Research & Development

Scaling CRO capabilities with smart finance

For more than 25 years, the trend of outsourcing R&D activities in the pharmaceutical industry has been gaining traction.<sup>1</sup> Driven by the need for continued innovation, outsourcing to a contract research organisation (CRO) has now become a mainstay for pharmaceutical, biotechnology and biomed companies of all sizes
Finance

Digitalisation in pharmaceutical manufacturing: investing for success

Amidst the current economic aftermath of COVID-19, new-generation digitalised technology (also known as Industry 4.0) is now, more than ever, crucial to enabling manufacturers in all sectors to improve performance through increased productivity, more accurate planning and forecasting, enhanced competitive capabilities and greater financial sustainability
Manufacturing

The digitalisation dilemma in pharmaceutical manufacturing

Drug production may be temporarily resistant to the Industry 4.0 juggernaut, but ignoring the benefits of digital technologies might put your business at risk in the long-term, suggests Alwyn Jones, Head of Pharmaceutical and Life Sciences UK & Ireland, Siemens Digital Industries
Research & Development

Private finance can unlock billions to relieve pressure and increase value for healthcare sector

New global research from Siemens Financial Services relates healthcare demand and resources to the patient outcomes they produce, resulting in a healthcare value indicator
Subscribe now